JANA Partners Addresses Charles River's Latest Defense of Proposed WuXi Acquisition (CRL, WX)
JANA Partners LLC today sent Charles River Laboratories International, Inc. (NYSE: CRL) a detailed critique of Charles River's revised investor presentation released earlier this week, in which Charles River once again seeks to persuade shareholders of the merits of its proposed acquisition of WuXi PharmaTech (Cayman) Inc. (NYSE: WX).
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.